Scholar Rock Inc. (SRRK) - Market Value

Scholar Rock brings together distinguished biologists motivated by a generous budget and the goal of combating muscle pathologies. The company currently remains insulated from macro cycles as it awaits the approval of new drugs for commercial launch. Diversified raw material supplies and strict temperature control of antibodies ensure margin stability. This price chart on GURU.Markets shows a capitalization of 5.26, confirming the issuer's market status.

SRRK Scholar Rock Holding Corporation: Market Capitalization in the range 07/04/2022 - 11/14/2026

Comprehensive metric breakdowns and analytics for Scholar Rock (SRRK)

- market price and analyst price targets:

Price Chart Scholar Rock Corp|SRRK - Fair Value Consensus

- market capitalization indicators:

Market Value Scholar Rock, Inc.|SRRK - Value Adjusted for Debt and Cash

- book value of equity indicators:

Net Assets per Single Share Scholar Rock|SRRK - Book Capitalization|Market Value to Book Value Ratio scholarrock.com|SRRK - Total Asset Value of Company

- debt and solvency information:

- business earnings and investment ratios data:

SRRK - Net Profit|Future Profit Scholar Rock|SRRK - Company Value to Net Income|Future Price to Earnings Scholar Rock Holding Corporation|SRRK - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple Scholar Rock Inc.|SRRK - Profit before interest, taxes and amortization|Net earnings per share for the last 12 months Scholar Rock|SRRK - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months scholarrock.com|SRRK - Earnings per share increase in current year|Net earnings per share growth forecast for next year Scholar Rock

- total revenue and sales volume data:

SRRK - Company Total Revenue|Company Projected Revenue Scholar Rock Corp|SRRK - Price-to-Revenue Ratio|Price-to-Projected Revenue Ratio Scholar Rock Inc.

Fundamental company analysis:SRRK (Scholar Rock Corp)

Portfolio diversification remains a critical requirement for hedging against volatility, even when a company's market capitalization demonstrates steady growth. For Scholar Rock (SRRK), this aggregate product of share price and total shares outstanding reflects a high market valuation of breakthroughs in muscle atrophy therapy, transforming scientific credibility into concrete business scale and confirming the brand's investment potential.

Key competitors